MRI Detection of Microbleeds in Glioma Patients

Detection of Microbleeds With MRI (SWI Sequences) in Glioma Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02899663

Acronym

SWIGLI

Enrollment

Registered

2016-09-14

Start date

2015-01-31

Completion date

Unknown

Last updated

2016-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma

Brief summary

Systematic retrospective medical chart and medical imaging file review of all patients receiving brain MRI for the follow-up of glioblastoma.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients * Diagnosed with brain glioblastoma * Receiving treatment with cranial radiotherapy and/or chemotherapy * Having at least one follow-up MRI conducted that used a susceptibility weighted imaging sequence

Exclusion criteria

* Underage * Absence of formal diagnosis of glioblastoma * No available medical imaging file with MRI susceptibility weighted imaging sequence

Design outcomes

Primary

Measure	Time frame
Number of microbleeds diagnosed with MRI (susceptibility weighted imaging sequence)	At the time of each MRI conducted within 5 years after diagnosis

Outcome results